Lineage Cell Therapeutics Inc (AMEX:LCTX)
$ 1.11 +0.030 (+2.78%) Market Cap: 281.99 Mil Enterprise Value: 232.34 Mil PE Ratio: 0 PB Ratio: 4.65 GF Score: 61/100

Lineage Cell Therapeutics Inc (LCTX) Transcripts

  • 1